SEC Form 4 · accession 0001209191-17-047862
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Arkowitz
Director
Period of report
Aug 4, 2017
Accepted (ET)
Aug 7, 2017 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 4, 2017 | P | 200 | $12.25 | A | 17,086 | D | |
| Common Stock | Aug 4, 2017 | P | 2,300 | $12.24 | A | 19,386 | D |
Table II — derivative securities
No Table II lines on this filing.